Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study

Response to lithium (Li) is highly variable in bipolar disorders (BD) and no clinical or biological predictors of long-term response have been validated to date. Using a genome-wide methylomic approach (SeqCapEpi), we previously identified seven differentially methylated regions (DMRs) that discrimi...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: Cynthia Marie-Claire, Cindie Courtin, Frank Bellivier, Jan Scott, Bruno Etain
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Subjects:
DNA methylation
bipolar disorder
lithium
biomarkers
response
MS-HRM
Online Access:https://www.mdpi.com/1424-8247/15/2/133

Internet

https://www.mdpi.com/1424-8247/15/2/133

Similar Items